Idiopathic Inflammatory Myopathy
Idiopathic Inflammatory Myopathy (IIM) is a group of diseases characterized by muscle inflammation and weakness, often leading to difficulty in performing daily activities.
Severe Autoimmune Diseases: CD19-targeted CAR T Cell Therapy
We are testing a new CAR T cell treatment for individuals with severe autoimmune diseases that haven't responded to other therapies. The goal is to see if this approach is safe and how well it works.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that primarily affects joints, causing pain, swelling, and stiffness, and can also affect other systems in the body.
Systemic Sclerosis
Systemic Sclerosis (Scleroderma) is a rare autoimmune disease that causes hardening and tightening of the skin and connective tissues, potentially affecting internal organs.
Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect multiple organs, leading to symptoms like fatigue, joint pain, and skin rashes.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZ Leuven
Rheumatology
Heverlee, Belgium
Centre Hospitalier Universitaire De Bordeaux
Hématologie clinique et thérapie cellulaire
Canéjan, France
Les Hopitaux Universitaires De Strasbourg
Rhumatologie
Eckbolsheim, France
Sponsor: Celgene Corp.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.